Stem cell-based and mesenchymal stem cell derivatives for coronavirus treatment.

Rafiee, Zeinab; Nejaddehbashi, Fereshteh; Nasrolahi, Ava; Khademi Moghadam, Fatemeh

Rafiee, Zeinab; Nejaddehbashi, Fereshteh; Nasrolahi, Ava; Khademi Moghadam, Fatemeh.

Afiliación

Rafiee Z; cellular and molecular research center, Medical Basic Sciences Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Nejaddehbashi F; Department of Anatomical Sciences, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Nasrolahi A; cellular and molecular research center, Medical Basic Sciences Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Khademi Moghadam F; Infectious Ophthalmologic Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Biotechnol Appl Biochem ; 69(5): 1942-1965, 2022 Oct.

Article en En | MEDLINE | ID: mdl-34555225

Asunto(s)

COVID-19; Exosomas; Trasplante de Células Madre Mesenquimatosas; Células Madre Mesenquimatosas; Humanos; SARS-CoV-2; COVID-19/terapia; Trasplante de Células Madre Mesenquimatosas/métodos; Células Madre Mesenquimatosas/metabolismo; Exosomas/metabolismo

Palabras clave

COVID-19; exosome; mesenchymal stem cells

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Mesenquimatosas / Exosomas / Células Madre Mesenquimatosas / COVID-19 Idioma: En Revista: Biotechnol Appl Biochem Asunto de la revista: BIOQUIMICA / BIOTECNOLOGIA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google